Accession Number: | 0001562180-20-000306 |
Date: | 2020-01-07 |
Issuer: | BLUEBIRD BIO, INC. (BLUE) |
Original Submission Date: |
LESCHLY NICK
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-01-07 | S | 10,163 | d | $89.97 | 56,712 | direct | ||
COMMON STOCK | 2020-01-07 | 0 | $0.00 | 168,699 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units. |
f2 | the range in prices for the transaction reported on this line was $89.50 to $90.42. the average weighted price was $89.9712. the reporting person will provide, upon request by the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
f3 | 185 shares were acquired under the bluebird bio, inc. employee stock purchase plan. |